MEC Global Events cordially invites participants to premier Global
Meeting on Cancer scheduled during November 13-14, 2020 Virtual Conference
which includes major keynote presentations, plenary talks and poster
presentation. Cancer 2020 is designed to gather the experts in the field of
oncology and related areas.
Cancer 2020 is the best opportunity for all the oncology and cancer
related doctors, oncology professionals, scientists, Radiologists, oncology
professionals, surgeons, Physicians, research scholars, students who are
working in oncology and its allied areas to explore their scientific research
across the globe. The theme of the conference is Exploring the Research
Advancements in Cancer and its therapy.
Who can Attend?
Market Report
The global cancer therapy
market is estimated to grow with a CAGR of 8.37% during the forecasted period.
Certain factors that are driving the market growth include increasing Patient
Assistance Programs (PAPs), increasing government initiatives for cancer
awareness, rising prevalence of cancer worldwide, and strong R&D
initiatives from key players.
More than 45 million
Americans do not have health insurance and millions more are underinsured;
eight out of 10 uninsured people are from working families. Among those with
health insurance, one out of 10 individuals, 65 years old or younger, and one
in three persons over 65 years do not have prescription drug coverage. Hence,
Patients Assistance Programs (PAPs) have emerged in an effort to help patients
who are lacking health insurance or prescription drug coverage get the medication they need. These programs
are provided by pharmaceutical companies to provide free or low-cost
prescription drugs to patients who are suffering from serious illnesses.
Cancer genetics is the science of genes inherited from parents which can inheriting mutations in one or more genes.
Cancer treatment vaccines, also called therapeutic vaccines, are a type of immunotherapy.
Cancer metabolism refers to the alterations in cellular metabolism pathways that are predominant in cancer cells.
Breast Cancer is the most common invasive cancer in women and the second leading cause of death after lung cancer.
Skin cancer is uncontrolled growth of abnormal cells in epidermis, caused by DNA damage that triggers mutations.
Brain Cancer is an overgrowth of cells in brain that forms masses called tumors.
Non-small cell lung cancer (NSCLC) is the most common type makes up about 80 to 85 percent of all cases.
Prostate cancer develops in prostate gland. It is the second-leading cause of cancer deaths deaths for men in the U.S